253345-80-1 Usage
General Description
2-HYDROXYMETHYL-3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)PYRIDINE HCL, also known as Triflusal, is a chemical compound used as an antiplatelet and antithrombotic agent to prevent blood clots. It inhibits the production of thromboxane A2, a substance that causes platelets to aggregate and blood vessels to constrict. Triflusal is commonly used in the treatment and prevention of cardiovascular diseases, including acute myocardial infarction and ischemic stroke. Its pharmacological effects include anti-inflammatory, antipyretic, and analgesic properties, making it a versatile medication for managing various conditions related to blood clotting and inflammation.
Check Digit Verification of cas no
The CAS Registry Mumber 253345-80-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,3,3,4 and 5 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 253345-80:
(8*2)+(7*5)+(6*3)+(5*3)+(4*4)+(3*5)+(2*8)+(1*0)=131
131 % 10 = 1
So 253345-80-1 is a valid CAS Registry Number.
253345-80-1Relevant articles and documents
Diversified synthesis of novel quinoline and dibenzo thiazepine derivatives using known active intermediates
Sharada,Satyanarayana Reddy,Sammaiah,Sumalatha
, p. 7959 - 7966 (2013/09/23)
The novel drug development to control resisting infections in conventional drug therapy is a need of today. Few antiulcer relative derivatives developed by approaching convergent synthesis. The derivatives synthesized successfully are dibenzo thiazepine-pyridine (SLN11-SLN15) and benzimidazole-hydroquinoline based derivatives (SLN16-SLN20). It involved the coupling through microwave, sonication and conventional techniques at final step. The efficient technology identified as sonication technique basically time and yield. The reported compounds were structural characterized by elemental analysis and spectral studies such as 1H, 13C NMR and MS.
